SAM #BAA-75N93026R00008

NIH NIAID Solicitation for TB Vaccine Research Center (IMPAc-TB)

The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc-TB) program. - Government Buyer: - Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Office of Acquisitions - Program Objective: - Accelerate tuberculosis (TB) vaccine development by supporting research on immune responses to Mycobacterium tuberculosis (Mtb) - Research must include: - Human-based studies - At least one animal model - Computational data integration - Consideration of HIV/SIV impact on immune responses - Products/Services Requested: - Research and development services focused on TB vaccine development - No specific products, part numbers, or OEMs are identified in the solicitation - Unique/Notable Requirements: - Proposals must integrate human, animal, and computational research components - Emphasis on tissue-specific and systemic immune responses - Estimated annual funding per award is approximately $5 million - 2-3 awards anticipated - Period of Performance: - Base period of one year with up to four option years (total up to five years) - Place of Performance/Delivery: - NIH/NIAID facilities at 5601 Fishers Lane, Bethesda/Rockville, MD - No OEMs or commercial vendors are specified; opportunity is open to qualified research organizations

Description

Please see the attached PDF for the solicitation notice (BAA-75N93026R00008).

View original listing